JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Tables

Table 2.1 List of some key inspection/licensing/accreditation/certification standards

Table 3.1 Extra-corporeal volume tables

Table 3.2 Citrate anticoagulants

Table 6.1 Discard limits

Table 7.1 Whole Blood, Leucocyte Depleted – additional tests

Table 7.2 Red Cells, Leucocyte Depleted – additional tests

Table 7.3 Red Cells in Additive Solution, Leucocyte Depleted – additional tests

Table 7.4 Red Cells, Washed, Leucocyte Depleted – additional tests

Table 7.5 Red Cells, Thawed and Washed, Leucocyte Depleted – additional tests

Table 7.6 Platelets, Pooled, Buffy Coat Derived, Leucocyte Depleted – additional tests

Table 7.7 Platelets, Apheresis, Leucocyte Depleted – additional tests

Table 7.8 Platelets in Additive Solution and Plasma – additional tests

Table 7.9 Platelets in Additive Solution, Leucocyte Depleted – additional tests

Table 7.10 Granulocytes, Apheresis – additional tests

Table 7.11 Granulocytes, Pooled, Buffy Coat Derived, in Additive Solution and Plasma
– additional tests

Table 7.12 Fresh Frozen Plasma, Leucocyte Depleted – additional tests

Table 7.13 Fresh Frozen Plasma, Methylene Blue Treated and Removed, Leucocyte Depleted
– additional tests

Table 7.14 Cryoprecipitate, Leucocyte Depleted – additional tests

Table 7.15 Cryoprecipitate Pooled, Leucocyte Depleted – additional tests

Table 7.16 Plasma, Cryoprecipitate Depleted, Leucocyte Depleted – additional tests

Table 7.17 Red Cells for Intrauterine Transfusion (IUT), Leucocyte Depleted – additional tests

Table 7.18 Whole Blood for Exchange Transfusion, Leucocyte Depleted – additional tests

Table 7.19 Red Cells for Exchange Transfusion, Leucocyte Depleted – additional tests

Table 7.20 Red Cells for Neonates and Infants, Leucocyte Depleted – additional tests

Table 7.21 Red Cells in Additive Solution for Neonates and Infants, Leucocyte Depleted
– additional tests

Table 7.22 Fresh Frozen Plasma, Neonatal Use, Methylene Blue Treated and Removed, Leucocyte
Depleted – additional tests

Table 7.23 Cryoprecipitate, Methylene Blue Treated and Removed, Leucocyte Depleted
– additional tests

Table 7.24 Platelets for Intrauterine Transfusion, Leucocyte Depleted – additional tests

Table 7.25 Platelets for Neonatal Use, Leucocyte Depleted – additional tests

Table 8.1 Steps for evaluation of novel components

Table 8.2 Evaluation of new red cell components for transfusion: recommended tests

Table 8.3 In vitro assessment

Table 8.4 Evaluation of new platelet components for transfusion

Table 8.5 Evaluation of novel plasma components

Table 8.6 Summary of testing numbers required for evaluations and validations

Table 9.1 Screening required for blood donations

Table 9.2 Screening required for tissue and stem cell donations

Table 11.1 Label colour coding

Table 11.2 Grading system for serological tests

Table 11.3 Requirements for conventional blood typing reagents

Table 11.4 Chequerboard test format

Table 11.5 Complement C3 and C4 activation

Table 12.1 Minimum release criteria for blood products with antibodies of probable
clinical significance

Table 12.2 Test monitor red cell samples

Table 15.1 Some blood group polymorphisms and associated gene sequence changes

Table 16.1 HLA antigens that are defined by serological typing (with broad specificities shown
in brackets)

Table 16.2 Characterisation of HLA-specific antibodies

Table 17.1 Current nomenclature for HNA and corresponding antibodies

Table 18.1 Current HPA nomenclature

Table 21.1 Temperature/time relationships for banked tissues

Table 21.2 Minimum donor/recipient data set to be kept

Table 22.1 Requirements for the timing of testing

Table 22.2 Label content adapted from FACT-JACIE

Table 22.3 Label content for HPC-C adapted from NetCord-FACT

Table 23.1 Standard blood group classifications

Table 23.2 Usage limitation

Table 23.3 Blood group and donation use label text

Table 24.1 Statements of product status

Table 25.1 Envelope definition

Table 25.2 Message protocol numbers

Table 25.3 Message protocol 000001: blood component dispatch information: administration line

Table 25.4 Message protocol 000001: blood component dispatch information: dispatch line

Table 25.5 Message protocol 000001: blood component dispatch information. Field 10: red cell
phenotype field – antigen codes

Table 25.6 Message protocol 000001: blood component dispatch information. Field 14:
platelet-specific phenotype

Table 25.7 Message protocol 000002: blood derivative dispatch information: administration line

Table 25.8 Message protocol 000002: blood derivative dispatch information: dispatch line

Table 25.9 Message protocol 000003: reagent dispatch information: administration line

Table 25.10 Message protocol 000003: reagent dispatch information: dispatch line

Table 25.11 Message protocol 000004: blood component dispatch acknowledgement:
administration line

Table 25.12 Message protocol 000004: blood component dispatch acknowledgement: dispatch line

Table 25.13 Message protocol 000005: blood component fate information: data line

Table 25.14 Message protocol 000005: blood component fate information. Field 8: wasted
classification code

Table 26.1 Blood bag base label dimensions (width × depth)

Table 26.2 Manufacturers’ Codabar codes

Table A1.1 Serological, virological and other preparations

Table A1.2 Coagulation preparations – WHO International Standards

Table A1.3 Coagulation preparations – British Standards

Table A2.1 Mapping from characters to ISO 7064 check values

Table A2.2 Example of displayed numbers